⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HURA News
TuHURA Biosciences, Inc. Common Stock
Form 8-K
sec.gov
HURA
TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
prnewswire.com
HURA
Form 8-K
sec.gov
HURA
Form 8-K
sec.gov
HURA
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers
prnewswire.com
HURA
Form 8-K
sec.gov
HURA
Form 8-K
sec.gov
HURA
TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update
prnewswire.com
HURA
TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
prnewswire.com
HURA
Form 8-K/A
sec.gov
HURA